- Advertisement -
The agreement is subject to the oral antiviral medication passing ongoing trials and regulatory approval.
The Pfizer drug is to be taken with the HIV medicine ritonavir.
Interim data from ongoing trials demonstrated an 89 per cent reduction in the risk of COVID-19-related…

